🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Approximately 207 hyperphosphatemic CKD patients not on dialysis will be en...
Status
Terminated
Location
Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie und Hämodialyse
Start Date
2009-01
Trial ID
NCT00833768
Treatments Being Tested
Fibroblast Growth Factor 23 (FGF23) is a molecule that has been implicated ...
Status
Completed
Location
Penn State Milton S. Hershey Medical Center
Start Date
2011-03
Trial ID
NCT01308242
Treatments Being Tested
FGF-23 is a newly described protein that is an important regulator of phosp...
Status
Completed
Location
UCLA
Start Date
2009-10
Trial ID
NCT00999037
Treatments Being Tested
The purpose of this clinical study is to compare the effects of Genz-644470...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00853242
Treatments Being Tested
This is a Phase 3, randomised, active controlled, multicentre extension stu...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01464190
Treatments Being Tested
The study investigators are interested in learning more about how drugs, th...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2020-03-05
Trial ID
NCT04278404
The comparison between nicotinamide and sevelamer aims to demonstrate, in c...
Status
Terminated
Location
Centre Hospitalier Général
Start Date
2010-01
Trial ID
NCT01011699
Treatments Being Tested
The study is designed to evaluate the ability of tenapanor alone or in comb...
Status
Completed
Location
Ardelyx Site #509
Start Date
2019-06-15
Trial ID
NCT03988920
Treatments Being Tested
Aims of the multi-center, randomized, treatment-controlled clinical trial a...
Status
Completed
Location
Edith Wolfson Medical Center
Start Date
2005-02
Trial ID
NCT01049815
Treatments Being Tested
A Phase 2a, Multicenter, Randomized, Open-label, Active Drug-controlled Tri...
Status
Recruiting
Location
The First Affiliated Hospital, Sun Yat-sen University
Start Date
2024-12-30
Trial ID
NCT06664125
Treatments Being Tested